Establishing an in vitro pipeline for the high-throughput quantification of epithelial permeability of gut bacterial metabolites
Brauer-Nikonow, A.; Voogdt, C. G. P.; Ribeiro, N. V.; Zimmermann, M.
Show abstract
The epithelium of the human gastrointestinal tract is key for controlling the absorption of small molecules and for forming a tight barrier between the gut microbiota and the host, thereby maintaining metabolic homeostasis. Both the microbiota and the barrier function of the intestinal epithelium have a role in pharmacokinetic variability of medical drugs. In this study, we developed a high-throughput workflow to assess the absorption of bacterially produced (drug) metabolites by intestinal epithelial cells through the combination of anaerobic bacterial cultures and human-intestine derived Caco2 cell cultures in a transwell system. To functionally monitor the barrier integrity during the experiments, we introduced a panel of marker compounds, whose concentration kinetics on either side of the epithelial monolayer indicates barrier integrity and transport. We employed this workflow to systematically probe the effect of different gut bacterial species on the epithelial absorption of 482 drugs and their 172 bacterially produced metabolites. While we could recapitulate known bacterial drug biotransformation reactions and expected drug metabolite absorption profiles, we also identified 33 new bacteria-drug pairs for which bacterial biotransformation alters epithelial permeability. Further, we combined the developed experimental workflow with untargeted metabolomics analysis to systematically study epithelial permeability of metabolites naturally produced by gut bacteria. Tracking the absorption kinetics of 397 bacterially produced metabolites revealed that the majority (>79%) of these metabolites do not pass the Caco2 monolayer, illustrating its role as a physical and metabolic barrier. In summary, we present a highly adaptable high-throughput workflow to quantitatively study the metabolic interactions at the intestinal microbiota-host interface which can impact pharmacokinetics, toxicokinetics, and human physiology.
Matching journals
The top 9 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- Bioluminescent zebrafish transplantation model for drug discovery 90%
- Methylene Blue Inhibits In Vitro the SARS-CoV-2 Spike - ACE2 Protein-Protein Interaction - A Mechanism That Can Contribute to Its Antiviral Activity Against COVID-19 90%
- Pharmacokinetics of caffeine: A systematic analysis of reported data for application in metabolic phenotyping and liver function testing 90%
Similar papers in this journal
- A novel in silico method employs chemical and protein similarity algorithms to accurately identify chemical transformations in the human gut microbiome 93%
- Merging Multi-OMICs with Proteome Integral Solubility Alteration Unveils Antibiotic Mode of Action 93%
- Organoid-derived Duodenum Intestine-Chip for preclinical drug assessment in a human relevant system 92%
Similar papers in this journal
- Pharmacological and behavioral effects of tryptamines present in psilocybin-containing mushrooms 91%
- Novel MBLs inhibitors screened from FDA-approved drug library restore the susceptibility of carbapenems to NDM-1-harbouring bacteria 90%
- A Systematic Assessment of Robustness in CNS Safety Pharmacology 89%
Similar papers in this journal
- The human hepatocyte TXG-MAPr: WGCNA transcriptomic modules to support mechanism-based risk assessment 90%
- Systematic Evaluation of High-Throughput PBK Modelling Strategies for the Prediction of Intravenous and Oral Pharmacokinetics in Humans 90%
- Identification of Functional Genetic Components Modulating Toxicity Response to PFOS using Genome-wide CRISPR Screens in HepG2/C3A cells 89%
Similar papers in this journal
- Evaluation of Connectivity Map shows limited reproducibility in drug repositioning 92%
- A Proteomic Platform to Identify Off-Target Proteins Associated with Therapeutic Modalities that Induce Protein Degradation or Gene Silencing 92%
- Sex-Dependent Responses in Mice to Indomethacin-Induced Injury and Gut Microbiome-Targeted Alleviation 92%
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.